Diffuse esophageal spasm pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
{{CMG}}; {{AE}} {{MSI}}  
{{CMG}}; {{AE}} {{MSI}}  
==Overview==
==Overview==
The exact pathogenesis of DES is not fully understood. Current high-resolution manometric studies suggests impairment of inhibitory neurons. These neurons use NO as neurotransmitter.
The exact pathogenesis of DES is not fully understood. Current high-resolution manometric studies suggests impairment of inhibitory neurons. These neurons use nitric oxide (NO) as neurotransmitter.


==Pathophysiology==
==Pathophysiology==

Revision as of 17:19, 21 November 2017

Diffuse esophageal spasm Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Diffuse esophageal spasm from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Diffuse esophageal spasm pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diffuse esophageal spasm pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diffuse esophageal spasm pathophysiology

CDC on Diffuse esophageal spasm pathophysiology

Diffuse esophageal spasm pathophysiology in the news

Blogs on Diffuse esophageal spasm pathophysiology

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Diffuse esophageal spasm pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]

Overview

The exact pathogenesis of DES is not fully understood. Current high-resolution manometric studies suggests impairment of inhibitory neurons. These neurons use nitric oxide (NO) as neurotransmitter.

Pathophysiology

Pathogenesis

  • The exact pathogenesis of DES is not fully understood. However, current high-resolution manometric studies suggest impairment of inhibitory myenteric plexus neurons in DES. These neurons use nitric oxide (NO) as neurotransmitter[1]. Hence, these patients may also have dysregulation of endogenous NO synthesis or/and degradation. Anti-ganglionic acetylcholine receptor antibodies (anti-gAChR-Abs) are reported in some cases[2]. The final result is premature and rapidly propagated or simultaneous contraction of smooth muscles of distal esophagus.

Genetics

There are reports of families with achalasia and esophageal spasm which supports the hypothesis that genetic traits may play role in pathogenesis of DES as well as association between the two disorders.[3] However, genetic inheritance is not fully established.

Associated Conditions

DES occurs in association with other motility disorders of esophagus like achalasia. Esophageal epiphrenic diverticulum is also commonly associated with DES[4].

Gross Pathology

  • On gross pathology, gross thickening of muscularis propria layer and LES which is due to hyperplasia (not hypertrophy) than normal subjects are characteristic findings of DES[5].

Microscopic Pathology

  • On microscopic histopathological analysis, degeneration of vagal fibres, inflammatory infiltration of myenteric plexus, and hyperplasia of smooth muscles are characteristic findings of DES. Data are limited due to rarity of disease and even less common need of surgery as a treatment.

References

  1. Yamato S, Spechler SJ, Goyal RK (1992). "Role of nitric oxide in esophageal peristalsis in the opossum". Gastroenterology. 103 (1): 197–204. PMID 1612326.
  2. Morimoto N, Takahashi S, Inaba T, Takamiya M, Kageyama Y, Morimoto M; et al. (2017). "A case of seropositive autoimmune autonomic ganglionopathy with diffuse esophageal spasm". J Clin Neurosci. 39: 90–92. doi:10.1016/j.jocn.2017.01.027. PMID 28214088.
  3. Frieling T, Berges W, Borchard F, Lübke HJ, Enck P, Wienbeck M (1988). "Family occurrence of achalasia and diffuse spasm of the oesophagus". Gut. 29 (11): 1595–602. PMC 1433819. PMID 3061886.
  4. Taniguchi Y, Takahashi T, Nakajima K, Higashi S, Tanaka K, Miyazaki Y; et al. (2017). "Multiple huge epiphrenic esophageal diverticula with motility disease treated with video-assisted thoracoscopic and hand-assisted laparoscopic esophagectomy: a case report". Surg Case Rep. 3 (1): 63. doi:10.1186/s40792-017-0339-6. PMC 5422214. PMID 28485002.
  5. Champion JK, Delise N, Hunt T (2001). "Myenteric plexus in spastic motility disorders". J Gastrointest Surg. 5 (5): 514–6. PMID 11986002.

Template:WH Template:WS